TrialJCO precision oncology2025

Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.

Rishi Surana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.